Literature DB >> 16455785

Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver.

David M Mutch1, Vanessa Crespy, Jennifer Clough, Colin J Henderson, Sofiane Lariani, Robert Mansourian, Julie Moulin, C Roland Wolf, Gary Williamson.   

Abstract

Using mice deficient in hepatic cytochrome P-450 oxidoreductase (POR), which disables the liver cytochrome P-450 system, we examined the metabolism and biological response of the anticarcinogenic flavonoid, quercetin. Profiling circulating metabolites revealed similar profiles over 72 h in wild-type (WT) and POR-null (KO) mice, showing that hepatic P450 and reduced biliary secretion do not affect quercetin metabolism. Transcriptional profiling at 24 h revealed that two- to threefold more genes responded significantly to quercetin in WT compared with KO in the jejunum, ileum, colon, and liver, suggesting that hepatic P450s mediate many of the biological effects of quercetin, such as immune function, estrogen receptor signaling, and lipid, glutathione, purine, and amino acid metabolism, even though quercetin metabolism is not modified. The functional interpretation of expression data in response to quercetin (single dose of 7 mg/animal) revealed a molecular relationship between the liver and jejunum. In WT animals, amino acid and sterol metabolism was predominantly modulated in the liver, fatty acid metabolism response was shared between the liver and jejunum, and glutathione metabolism was modulated in the small intestine. In contrast, KO animals do not regulate amino acid metabolism in the liver or small intestine, they share the control of fatty acid metabolism between the liver and jejunum, and regulation of sterol metabolism is shifted from the liver to the jejunum and that of glutathione metabolism from the jejunum to the liver. This demonstrates that the quercetin-mediated regulation of these biological functions in extrahepatic tissues is dependent on the functionality of the liver POR. In conclusion, using a systems biology approach to explore the contribution of hepatic phase 1 detoxification on quercetin metabolism demonstrated the resiliency and adaptive capacity of a biological organism in dealing with a bioactive nutrient when faced with a tissue-specific molecular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455785     DOI: 10.1152/ajpgi.00565.2005

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  7 in total

1.  Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance.

Authors:  G P Holloway; C J Chou; J Lally; T Stellingwerff; A C Maher; O Gavrilova; M Haluzik; H Alkhateeb; M L Reitman; A Bonen
Journal:  Diabetologia       Date:  2011-03-26       Impact factor: 10.122

Review 2.  Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models.

Authors:  Xi-Ling Jiang; Frank J Gonzalez; Ai-Ming Yu
Journal:  Drug Metab Rev       Date:  2010-09-21       Impact factor: 4.518

3.  Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure.

Authors:  Yi Zhu; Xinxin Ding; Cheng Fang; Qing-Yu Zhang
Journal:  Mol Pharmacol       Date:  2013-11-01       Impact factor: 4.436

Review 4.  Differential Impact of Flavonoids on Redox Modulation, Bioenergetics, and Cell Signaling in Normal and Tumor Cells: A Comprehensive Review.

Authors:  Asimina Kerimi; Gary Williamson
Journal:  Antioxid Redox Signal       Date:  2017-09-28       Impact factor: 8.401

5.  Quercetin induces hepatic lipid omega-oxidation and lowers serum lipid levels in mice.

Authors:  Elise F Hoek-van den Hil; Jaap Keijer; Annelies Bunschoten; Jacques J M Vervoort; Barbora Stankova; Melissa Bekkenkamp; Laure Herreman; Dini Venema; Peter C H Hollman; Eva Tvrzicka; Ivonne M C M Rietjens; Evert M van Schothorst
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

6.  Contrasting effects of Deadend1 (Dnd1) gain and loss of function mutations on allelic inheritance, testicular cancer, and intestinal polyposis.

Authors:  Jennifer L Zechel; Stephanie K Doerner; Angela Lager; Paul J Tesar; Jason D Heaney; Joseph H Nadeau
Journal:  BMC Genet       Date:  2013-06-17       Impact factor: 2.797

7.  High-level integration of murine intestinal transcriptomics data highlights the importance of the complement system in mucosal homeostasis.

Authors:  Nirupama Benis; Jerry M Wells; Mari A Smits; Soumya Kanti Kar; Bart van der Hee; Vitor A P Martins Dos Santos; Maria Suarez-Diez; Dirkjan Schokker
Journal:  BMC Genomics       Date:  2019-12-30       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.